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ABSTRACT
Objective: To study the association of the two endocrinal disorders (diabetes mellitus and thyroid disease) in randomly selected geriatric patients.
Methods: The study includes 80 patients in geriatric age groups with Type-2 diabetes mellitus visiting the medicine outpatients department. Thyroid 
profile was assayed in Type-2 diabetic patients.
Results: It was noted that thyroid dysfunction was prevalent in 41 (51.25%) out of the 80 geriatric age group patients with 31 (38.75%) being 
hypothyroidism, 7 (8.7%) having subclinical hypothyroidism, and 3 (3.7%) having a hyperthyroid state.
Conclusion: The study shows that screening should be strongly recommended for all Type-2 diabetics to rule out thyroid dysfunction in patients with 
increasing age.
Keywords: Thyroid profile, Geriatric patients, Diabetes mellitus.
INTRODUCTION
Thyroid disease (TD) is common in the general population and its 
prevalence increases with age [1]. Altered serum thyroid-stimulating 
hormones (TSHs) levels with normal or altered thyroid hormone, 
free triiodothyronine (FT3) and free thyroxine (FT4) is defined as 
thyroid dysfunction [2]. Different TDs include Hashimoto’s thyroiditis, 
hyperthyroidism, and hypothyroidism [3]. Hypothyroidism is a state 
in which the thyroid organ does not make enough thyroid hormone. 
Iodine insufficiency is frequently referred to as the most well-known 
reason for hypothyroidism overall, however, it can be brought about by 
numerous different variables. It can come about because of the absence 
of a thyroid organ or from iodine-131 treatment, and can likewise 
be connected with expanded anxiety [4]. The assessment of thyroid 
function by modern assays is both reliable and inexpensive. Screening 
for thyroid dysfunction is indicated in certain high-risk groups such 
as the elderly and those with other endocrinal disorders especially 
diabetes mellitus [1].
Diabetic patients have a higher prevalence of thyroid disorders 
compared with the normal population. A number of reports have also 
indicated a higher than normal prevalence of thyroid disorders in 
Type-2 diabetic patients with hypothyroidism being the most common 
thyroid disorder and especially in older women [1].
Hypothyroidism is usually autoimmune in origin presenting as either 
primary atrophic hypothyroidism or Hashimoto’s thyroiditis. Thyroid 
failure secondary to radioactive iodine therapy or thyroid surgery is 
also common. Rarely, pituitary or hypothalamic disorders can result in 
secondary hypothyroidism [1].
Millions of people in India are hypothyroid and are on hormone 
replacement therapy. By contrast, hyperthyroidism is much less 
common with a female to male ratio of 9:1. Grave’s disease is the most 
common cause and primarily affects young adults. Toxic multi-nodular 
goiter tends to affect the older age groups. Moreover, nodular thyroid 
structure and parenchymatous goiter occur more frequently in Type-2 
diabetics [5].
According to the WHO and UN, 2001, people aged 45-59 years are 
considered “middle aged” and those above 60 years are considered to 
be geriatrics, though there is no fixed or mandatory criteria or guideline. 
In the real world, especially, where jobs and pension schemes and other 
such scenarios where benefits are concerned, people over 65 years are 
considered to be geriatric [6]. In this study, though people over 60 years 
will be considered as geriatric.
The presence of thyroid dysfunction may affect glycemic control in 
diabetics. Hyperthyroidism is typically associated with worsening 
glycemic control and increased insulin requirements. There is 
underlying increased hepatic gluconeogenesis, rapid gastrointestinal 
absorption of glucose, and probably increased insulin resistance also. 
Indeed, thyrotoxicosis may unmask latent diabetes [1].
Although wide ranging changes in carbohydrate metabolism are seen 
in hypothyroidism, clinical manifestations of these abnormalities 
are seldom conspicuous. However, the reduced rate of insulin 
degradation may lower the exogenous insulin requirements. The 
occurrence of hypoglycemic states is uncommon in isolated thyroid 
hormone deficiency and should raise the doubt of hypopituitarism 
in a patient with hypothyroidism. More importantly, hypothyroidism 
is accompanied by a variety of abnormalities in lipid metabolism 
including elevated triglyceride and low-density lipoprotein (LDL) 
concentrations. Even subclinical hypothyroidism can worsen the 
coexisting dyslipidemia commonly found in Type-2 diabetics and hence 
further increase the risks of cardiovascular events. Adequate hormone 
replacement will reverse the lipid abnormalities [1,5].
All steps of lipids metabolism are involved by thyroid hormones leading 
to development of qualitative and quantitative changes of serum 
lipids [7].
In conclusion, thyroid dysfunction is common in diabetics and can 
produce significant metabolic disturbances with serious outcomes. 
Therefore, regular screening for thyroid abnormalities in all diabetic 
patients will allow early detection and effective treatment of thyroid 
dysfunction to prevent morbidity. A sensitive serum TSH assay is 
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the screening test of choice. In Type-2 diabetic patients, a TSH assay 
should be done at diagnosis and then repeated at least every 5 years 
(if euthyroid) [1].
METHODS
The study was performed after approval from the Institutional Ethical 
Committee and written consent was obtained from all participant in 
our study.
Patients selection
This study conducted between May 2014 and November 2015 in 80 
previously diagnosed Type-2 diabetic patients attending the outpatient 
department and admitted in-patients of Medicine Department of RIMS, 
Ranchi, were randomly selected and screened for thyroid dysfunction 
after obtaining a detailed history, also pertaining to thyroid and 
diabetes-related symptoms, and then subjecting them to an equally 
detailed general physical examination.
Inclusion criteria
A total of 80 patients in the geriatric age group with Type-2 diabetes 
mellitus.
Exclusion criteria
1. Patients with Type-1 diabetes mellitus
2. Patients on hormone replacement therapy
3. Patients on steroids
4. Pregnant women
5. Patients on drugs known to cause hypothyroidism (propranolol, 
iopanoic acid, iodide, amiodarone, salicylates, phenytoin, 
glucocorticoids, lithium, amphetamines, sertraline, aminoglutethimide, 
dopamine, somatostatin, octreotide, interleukins, heroin)
6. Patients with cirrhosis of liver
7. Patients with renovascular hypertension or renal failure
8. Patients with heart failure.
Sample collection
Fasting blood samples were collected for estimation of blood glucose 
and thyroid profile. Blood glucose was done by hexokinase method 
and thyroid profile by chemiluminescent microparticle immunoassay 
method.
Statistical analysis
All data were expressed as the mean and standard deviation, the 
SPSS 20 software was used for the statistical analysis. The statistical 
significance was analyzed in the subjects using the Student’s t-test. 
Significance was considered for all tests (p<0.05). For Student’s t-test 
significance represented as (*) less significant (p<0.05), (**) significant 
(p<0.01), and (***) highly significant (p<0.001).
RESULTS
It was noted that thyroid dysfunction was prevalent in 41 (51.25%) 
in the studied patients with 31 (38.75%) being hypothyroid, 7 (8.7%) 
having subclinical hypothyroidism, and 3 (3.7%) having a hyperthyroid 
state (Table 1 and Fig. 1).
Thyroid dysfunction was predominantly seen in females (77 in the 
studied age groups) with the prevalence rising with increasing age.
Maximum number of patients, 37 (46.25%) had a 10-14 years duration 
of diabetes.
A total of 38 patients out of 80 in the study group had dyslipidemia of 
which 21 (55.26%) patients were found to have significantly altered 
serum lipids levels. Only 3 (7.8%) patients out of 38 with dyslipidemia 
also had subclinical hypothyroidism.
The prevalence of anteroseptal wall ischemia in the studied age group 
was observed to be 7 (17.0%). Lateral wall ischemia was seen to be 
present in 6 (14.6%) patients. Inferior wall ischemia was revealed in 
the electrocardiograms of 11 (26.8%) patients.
DISCUSSION
Thyroid dysfunction was predominantly seen in females (a total of 
80 patients with 77 in the study groups) with the prevalence rising with 
increasing age.
A significant association was seen between increasing body mass 
index (BMI) values with the prevalence of TD where 26 (78%) of the 
32 hypothyroid patients in the study group had a BMI >25 (Grade I 
and II obesity) with diabetes.
Both diabetes and TD as separate entities lead to significant 
cardiovascular morbidity due to alterations in the metabolism of 
lipids leading to increased atherogenicity. The presence of both 
endocrinal disorders in patients heightens the risk of morbidity 
and also mortality manifold which is evident by the presence of 
dyslipidemia in most of these patients and the direct effect of both in 
causing ischemic heart disease. 38 (47.5%) patients in study groups 
were found to have altered serum lipid values of which 19 (23.7%) 
patients had hypothyroidism.
Thyroid function tests done in a study population of 298 Type-2 
diabetics conducted by Nobre et al. in 2002, in Europe showed that 
38 (12.7%) of them suffered from thyroid dysfunction-10.7% had 
hypothyroidism (>2/3rd with subclinical hypothyroidism) and 2% had 
hyperthyroidism. In 31 cases (10.4%), the diagnosis was performed 
“de nova.” TD was more prevalent among females and the elderly [8].
In a study conducted by Radaideh et al. with 908 Type-2 diabetics and 
304 non-diabetics at Amman, Jordan, the overall prevalence of TD in 
diabetics was found to be 12.5% of which 5.9% were known to have 
TD and the rest (6.6%) were newly diagnosed cases as a direct result of 
screening. The most common was subclinical hypothyroidism (4.1%). 
The prevalence of TD was 6.6% in the control group [9].
An Indian study done at GND Hospital, Amritsar by Bal et al. in 2003, 
with 184 Type-2 diabetics showed that TD was present in 78 (40.4%) 
cases (50 males and 28 females) but autoimmune thyroiditis (AT) 
was present in 32 (17.4%) cases (8 males and 24 females). There was 
a positive correlation with the age of the patients in the TD group, 
but there was no significant correlation found with complications of 
Fig. 1: Thyroid dysfunction in geriatric Type-2 diabetic patients
Table 1: Thyroid status of the patients studied
Age group Normal euthyroid Hypothyroidism Subclinical hypothyroidism Hyperthyroidism
Geriatric (>60 year) n=80 39 (48.75%) 31 (38.75%) 7 (8.7%) 3 (3.7%)
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diabetes. There was no correlation of age, severity or complications in 
the AT group but these findings were significantly more in females [10].
In a study sample of 100 Type-2 diabetics at Chennai, the prevalence 
of TD was found to be 15% with subclinical hypothyroidism - 11%, 
hypothyroidism - 1%, subclinical hyperthyroidism - 2% and 
hyperthyroidism - 1%. The prevalence was higher than that in the 
general population and in females [11].
In another study of 120 Type-2 diabetics conducted at Hyderabad by 
Ramaswamy in 2003, hypothyroidism was seen in 32 (27%) cases of which 
10% had subclinical hypothyroidism with 80% of them being females. 70% 
of the patients with hypothyroidism were between 40 and 60 years of age. 
Only in 1% cases, the appearance of hypothyroidism had preceded Type-2 
diabetes and in 2% hypothyroidism cases the titers of antimitochondrial 
antibody were significant and goiter was noted in 2% of the patients [12].
The Colorado TD Prevalence Study conducted under Canaris in the 
year 2000 showed that the consequences of untreated subclinical 
hypothyroidism include cardiac dysfunction or adverse cardiac endpoints 
(atherosclerotic disease and cardiovascular mortality), elevation of total 
and LDL cholesterol, systemic hypothyroid symptoms or neuropsychiatric 
symptoms, progression to overt symptomatic hypothyroidism [13].
Zondek [14] detected an increased association of coronary heart disease 
in hypothyroidism. In a study by Sawin et al. [15] on elderly women, 3% 
were found to be hypothyroid. In another study conducted by Bahemuka 
and Hodkinson [16], 2.3% of elderly women had hypothyroidism. Kutty 
et al. [17] showed that clinically overt hypothyroidism in patients is 
associated with hyperlipidemia.
CONCLUSION
Thyroid dysfunction is seen in a significant percentage of the 
previously diagnosed Type-2 diabetics with the most predominant 
dysfunction being overt hypothyroidism followed by subclinical 
hypothyroidism, females being predominantly affected. The prevalence 
of hyperthyroidism was very less in these patients. Hypothyroidism 
was seen more in patients with increasing age was noticed with a 
higher prevalence among the older patients in the geriatric age mark 
and was associated with an increase in BMI.
The presence of secondary dyslipidemia due to hypothyroidism and 
increased BMI as a consequence of previously undiagnosed hypothyroidism 
is a major risk factor for atherosclerosis and its accompanying vascular 
complications especially if these patients are affected with a dual 
endocrinological disorder, the other being diabetes mellitus.
In conclusion screening should be strongly recommended for all 
diabetes to rule out thyroid disfunction especially in patients with 
increasing age and obesity to timely diagnose and prevent major 
cardiovascular morbidity and mortality.
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